Archive:
Every second patient with hepatitis C knows nothing about their disease and is not treated, even though there are a number of promising therapies. Researchers at IQVIA show that artificial intelligence could close this gap. They developed an algorithm to identify people at high risk of HCV based on patient data.
07.12.2020
Die Ruhr-Universität Bochum (RUB) war 1962 die erste Universitätsneugründung in der Bundesrepublik, mit aktuell immerhin zehn Fakultäten, darunter die Medizinische Fakultät, u.a. mit der Abteilung für Allgemeinmedizin. Die Anfänge der RUB-Allgemeinmedizin reichen mehr als 25 Jahre zurück. Was zunächst als kleiner Lehrbereich begann, wurde im Laufe der Jahre zu einer eigenständigen Abteilung, die zunehmend auch Projekte in der Versorgungsforschung realisiert. Mit der Neubesetzung des Lehrstuhls durch Univ.-Prof. Dr. med. Horst Christian Vollmar wurde im Jahr 2018 die Forschung neu aufgestellt und strategisch auf vier Herausforderungen fokussiert.
07.12.2020
Nearly 5,000 scientists and healthcare professionals have now co-signed the so-called "John Snow Memorandum" on Covid-19, which was published in the journal "The Lancet" on October 10, 2020, and is also available on the online portal of the memorandum of the same name. In this highly compelling statement, the authors call for "clear communication about the risks posed by Covid-19 and effective strategies to combat them," but vehemently warn against "infection-acquired population immunity" that would lead to a low-risk population. This, according to the authors of the memorandum, is "a dangerous fallacy that is not supported by scientific evidence." Two significant contributions from Germany support this international initiative: a statement from the Society for Virology (GfV) and a statement from the group of authors led by Prof. Dr. med. Matthias Schrappe, who, on the occasion of the conference of the Federal Chancellor with the Minister-Presidents of the Länder on 14 October 2020, supplemented her six position papers published in „Monitor Versorgungsforschung“ with an „urgent ad-hoc statement“.
07.12.2020
The “Primary Care Congress” (PVK), which was also well received by the Austrian public media, took place for the 5th time this year - this time, of course, completely online and free of charge. Once again organized by the Institute for General Medicine and Evidence-Based Health Care Research (IAMEV) at the Medical University of Graz together with the Austrian Forum for Primary Care (OEFOP), this congress has long been established in the Austrian healthcare event landscape due to the dimensions of Corona and the great importance for it Primary care is dealing with the corona pandemic. The topic: “Primary care in times of a pandemic”. The congress program offered a mix of international/national keynotes, sessions on practical experiences and healthcare-relevant topics for practice, as well as live webinars with the opportunity for discussion for all online participants.
07.12.2020
Das im Auftrag des Spitzenverbands Bund der Krankenkassen (GKV-Spitzenverband) vom Prognos-Institut erstellte Gutachten zum „Stand der klinischen Krebsregistrierung zum 31.12.2019“ erntet Kritik. „Das Gutachten beruht ausschließlich auf Angaben aus den Erfüllungsberichten der Krebsregister, die von den jeweiligen Landeskrankenkassen zur Verfügung gestellt wurden. Externe Experten wurden bei der Evaluation der Daten nicht hinzugezogen und auch die klinischen Krebsregister selbst, wie in der Vergangenheit üblich, wurden nicht gehört“, rügt Prof. Dr. Monika Klinkhammer-Schalke, Vorstandsvorsitzende der Arbeitsgemeinschaft Deutscher Tumorzentren (ADT). Es sei fraglich, ob die Kassen angesichts ihres unmittelbaren Interessenkonflikts die notwendige Unabhängigkeit für die Bewertung der Leistungen der Klinischen Krebsregister besäßen.
07.12.2020
Für den medizinischen Fortschritt werden Gesundheitsdaten immer wichtiger. Die Nutzung von Gesundheitsdaten ist hierzulande jedoch stark eingeschränkt – und bewegt sich in Deutschland im Spannungsfeld von gewünschten Innovationen und der informationellen Selbstbestimmung der Bürger. Gerade jetzt braucht es einen politischen Schub für eine stärkere Nutzung der Daten in Deutschland. Warum ist dies wichtig und welchen Mehrwert haben Patienten, Kostenträger, Leistungserbringer und Industrie, wenn sie anonymisierte oder pseudonymisierte Gesundheitsdaten aus dem Alltag – sogenannte Real-World-Data – nutzen dürfen? Diese und weitere Fragen diskutierten Vertreter aus Politik, Wirtschaft und Verwaltung im Rahmen der Vorstellung der neuen Analyse der BDI-Initiative Gesundheit digital zur Nutzung von Gesundheitsdaten in Versorgung, Forschung und Entwicklung.
07.12.2020
Although completed in November 2019, the report “International data bases for health care research” prepared on behalf of the Central Institute for Statutory Health Care in Germany (Zi) was only published at the end of September this year due to the Covid-19 pandemic. The topic is now and especially with regard to Covid-19 explosive, because in this international comparative study, the health economist Prof. Dr. Reinhard Busse (TU Berlin) and his team are investigating how the data basis in Germany could be improved: There is still a lot of room for improvement!
07.12.2020
Depending on the active ingredient and indication, biosimilars achieve market penetration at different rates. In oncology, the first imitators of monoclonal antibodies were only introduced in Germany years after the patent had expired and were therefore only able to generate savings in the pharmaceutical market belatedly. With the end of the market exclusivity of bevacizumab in June 2020, the first biosimilars had already received their approval from the European Medicines Agency (EMA) and were directly available to prescribers. The market analysis by INSIGHT Health shows increasing numbers of prescriptions for biosimilar monoclonal antibodies, the reason for which can be found not only in health policy measures, but also in the growing acceptance among doctors as a therapeutic option in oncology.
07.12.2020
„"We will continue to work hard in 2021 to use this momentum to advance healthcare and service issues in the Northeast together with our partners." Daniela Teichert, Chair of the Board of AOK Nordost, said this in an interview with "Monitor Versorgungsforschung." The first year of her term, which began in January of this year, was dominated by the coronavirus pandemic – unlike the many years of her predecessor, Frank Michalak. Nevertheless, day-to-day business, diverse projects, and other major challenges such as digitalization could not be neglected. Teichert: "Digital applications are not an end in themselves and should not be viewed as a separate pillar of healthcare."“
07.12.2020
Broad-based healthcare providers and health services research – the relationship is complex. The German Network for Health Services Research aims to better link healthcare practice and health services research. Guided by the conviction that mutual presentation and dialogue can help overcome structural restrictions, a session entitled "Health Services Research and Broad-based Healthcare Providers" took place as part of the 2020 German Congress for Health Services Research. Invited healthcare practitioners presented the concepts, relevance, and evaluations of their models and projects, and reflected on the possibilities and limitations of broad-based healthcare providers in health services research based on their many years of personal experience.